Jan 14, 2020 / 07:00PM GMT
R.A. McDonough;JPMorgan;Analyst -
Great. Hi, I'm R.A. McDonough from JPMorgan Investment Banking. Thank you all so much for joining us this morning.
Patrick Soon-Shiong is with us, and very exciting opportunity to hear about 3 companies, actually. He's going to be presenting today, ImmunityBio, which is a very large private immunotherapy company and then NantKwest and NantHealth, which are both public, and Patrick's going to talk about the intersection of all 3 companies as well as share some very exciting clinical results that he's had amongst the companies.
So with that, I'll turn it over to Patrick.
Patrick Soon-Shiong - NantKwest, Inc. - Executive Chairman & CEO
Thanks, R.A. Every year, I confuse JPMorgan about which companies I'm going to be presenting. So this year, I think it's a year where we're trying to really consider the consolidation.
And I'll just start with NantHealth, and we won't have any slides on NantHealth. But I think what was exciting for me to hear, the virology
NantKwest Inc and ImmunityBio at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers